[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

ANI Pharma Inc 104 Carnegie Center Drive Suite 300 Princeton NJ 08540 USA

www.anipharmaceuticals.com Employees: 970 P: 609-759-1810 F: 218-634-3540

Sector:

Medical

Description:

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture and metoclopramide tablets. In addition, it offers contract manufacturing services for other pharmaceutical companies. The company serves through wholesalers, smaller regional distributors and chains and pharmacy and retail outlets primarily in the United States. ANI Pharmaceuticals, Inc., formerly known as BioSante Pharmaceuticals, Inc., is headquartered in Baudette, MN.

Key Statistics

Overview:

Market Capitalization, $K 1,785,710
Enterprise Value, $K 1,809,200
Shares Outstanding, K 22,745
Float, K 20,903
% Float 91.90%
Short Interest, K 3,563
Short Float 15.66%
Days to Cover 12.96
Short Volume Ratio 0.58
% of Insider Shareholders 8.10%
% of Institutional Shareholders 76.05%

Financials:

Annual Sales, $ 883,370 K
Annual Net Income, $ 78,340 K
Last Quarter Sales, $ 237,460 K
Last Quarter Net Income, $ 29,490 K
EBIT, $ 213,230 K
EBITDA, $ 304,650 K

Growth:

1-Year Return 35.81%
3-Year Return 63.56%
5-Year Return 128.36%
5-Year Revenue Growth 323.72%
5-Year Earnings Growth 125.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 2.05 on 05/08/26
Next Earnings Date 08/14/26
Earnings Per Share ttm 6.68
EPS Growth vs. Prev Qtr -15.15%
EPS Growth vs. Prev Year 22.63%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 07/18/13

ANIP Ratios

Ratio
Price/Earnings ttm 12.14
Price/Earnings forward 10.19
Price/Earnings to Growth N/A
Return-on-Equity % 27.51%
Return-on-Assets % 10.02%
Profit Margin % 8.87%
Debt/Equity 0.54
Price/Sales 2.09
Price/Cash Flow 8.16
Price/Book 3.30
Book Value/Share 24.57
Interest Coverage 5.78
60-Month Beta 0.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.